Truncated midkine as a marker of diagnosis and detection of nodal metastases in gastrointestinal carcinomas

被引:35
作者
Aridome, K
Takao, S
Kaname, T
Kadomatsu, K
Natsugoe, S
Kijima, F
Aikou, T
Muramatsu, T
机构
[1] Kagoshima Univ, Fac Med, Dept Surg 1, Kagoshima 890, Japan
[2] Kumamoto Univ, Sch Med, Inst Mol Embryol & Genet, Dept Dev Genet, Kumamoto 862, Japan
[3] Nagoya Univ, Sch Med, Dept Biochem, Showa Ku, Nagoya, Aichi 466, Japan
关键词
midkine; processing variant; metastasis; lymph node; gastrointestinal carcinoma;
D O I
10.1038/bjc.1998.517
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Midkine (MK) is a growth factor identified as a product of a retinoic acid-responsive gene. A truncated form of MK mRNA, which lacks a sequence encoding the N-terminally located domain, was recently found in cancer cells. We investigated the expression of the truncated MK mRNA in specimens of 47 surgically removed human gastrointestinal organs using polymerase chain reaction. Truncated MK was not detected in all of the 46 corresponding non-cancerous regions. On the other hand, this short MK mRNA was expressed in the primary tumours in 12 of 16 gastric cancers, 8 of 13 colorectal carcinomas, five of nine hepatocellular carcinomas, two of two oesophageal carcinomas and one ampullary duodenal cancer. In addition, truncated MK was detectable in all of the 14 lymph node metastases but in none of three metastatic sites in the liver, suggesting that truncated MK mRNA could become a good marker of nodal metastases in gastrointestinal tract.
引用
收藏
页码:472 / 477
页数:6
相关论文
共 33 条
[21]  
MERENMIES J, 1990, J BIOL CHEM, V265, P16721
[22]   Expression of truncated midkine in human colorectal cancers [J].
Miyashiro, I ;
Kaname, T ;
Nakayama, T ;
Nakamori, S ;
Yagyu, T ;
Monden, T ;
Kikkawa, N ;
Nishisho, I ;
Muramatsu, T ;
Monden, M ;
Akiyama, T .
CANCER LETTERS, 1996, 106 (02) :287-291
[23]   Midkine expression in human breast cancers: Expression of truncated form [J].
Miyashiro, I ;
Kaname, T ;
Shin, E ;
Wakasugi, E ;
Monden, T ;
Takatsuka, Y ;
Kikkawa, N ;
Muramatsu, T ;
Monden, M ;
Akiyama, T .
BREAST CANCER RESEARCH AND TREATMENT, 1997, 43 (01) :1-6
[24]  
MORI M, 1995, CANCER RES, V55, P3417
[25]   PURIFICATION OF RECOMBINANT MIDKINE AND EXAMINATION OF ITS BIOLOGICAL-ACTIVITIES - FUNCTIONAL COMPARISON OF NEW HEPARIN BINDING-FACTORS [J].
MURAMATSU, H ;
MURAMATSU, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 177 (02) :652-658
[26]   LOCALIZATION OF HEPARIN-BINDING, NEURITE OUTGROWTH AND ANTIGENIC REGIONS IN MIDKINE MOLECULE [J].
MURAMATSU, H ;
INUI, T ;
KIMURA, T ;
SAKAKIBARA, S ;
SONG, XJ ;
MARUTA, H ;
MURAMATSU, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 203 (02) :1131-1139
[27]  
MURAMATSU T, 1993, INT J DEV BIOL, V37, P183
[28]  
NAKAGAWARA A, 1995, CANCER RES, V55, P1792
[29]  
OBrien T, 1996, CANCER RES, V56, P2515
[30]   Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ-line insertion of an endogenous retrovirus [J].
Schulte, AM ;
Lai, SP ;
Kurtz, A ;
Czubayko, F ;
Riegel, AT ;
Wellstein, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (25) :14759-14764